Effects of sugammadex and rocuronium mast cell number and degranulation in rat liver

We investigated the effect of rocuronium‐ and sugammadex‐induced mast cell increase and degranulation in rat portal triads. Forty‐two rats, in six groups, received either rocuronium 1 mg.kg−1; sugammadex 15 mg.kg−1; sugammadex 100 mg.kg−1; rocuronium 1 mg.kg−1 and 5 min later, sugammadex 15 mg.kg−1; rocuronium 1 mg.kg−1 and 5 min later, sugammadex 100 mg.kg−1; or isotonic saline. Total mast cell numbers were significantly higher with rocuronium only, than in all other groups (p < 0.003), although in all active groups, the number was greater than the control. Total mast cell number was significantly higher with rocuronium and low‐dose sugammadex compared with low‐dose sugammadex only. The number of tryptase‐positive mast cells with rocuronium only was significantly higher than in all other groups (p < 0.003). Tryptase‐positive mast cell numbers in both groups receiving both rocuronium and sugammadex were significantly higher compared with both groups receiving sugammadex only. Rocuronium increased mast cell numbers, and degranulation was mitigated by sugammadex. These results suggest that sugammadex may be beneficial in treatment of rocuronium‐induced anaphylaxis.

[1]  L. Goodnough,et al.  In reply , 2014, Transfusion.

[2]  P. Platt,et al.  The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model * , 2012, Anaesthesia.

[3]  A. Funnell,et al.  A further case of rocuronium-induced anaphylaxis treated with sugammadex. , 2011, British journal of anaesthesia.

[4]  D. Ebo,et al.  Rocuronium‐induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment , 2011, Anaesthesia.

[5]  J. R. Ortiz-Gómez,et al.  Allergy to low dose sugammadex , 2011, Anaesthesia.

[6]  C. Miller,et al.  Tryptase Staining of Mast Cells May Differentiate Eosinophilic Esophagitis from Gastroesophageal Reflux Disease , 2011, The American Journal of Gastroenterology.

[7]  T. Turkstra,et al.  Mitigation of rocuronium‐induced anaphylaxis by sugammadex: the great unknown , 2010, Anaesthesia.

[8]  J. McKinlay,et al.  Severe bronchospasm or anaphylaxis? , 2010, Anaesthesia.

[9]  R. Guéant-Rodriguez,et al.  Hypersensitivity reactions to neuromuscular blocking agents. , 2008, Current pharmaceutical design.

[10]  G. Pejler,et al.  Biology of mast cell tryptase , 2006 .

[11]  J. Stensballe,et al.  Reversal of Rocuronium-induced Neuromuscular Block by the Selective Relaxant Binding Agent Sugammadex: A Dose-finding and Safety Study , 2006, Anesthesiology.

[12]  J. van Egmond,et al.  Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys. , 2006, British journal of anaesthesia.

[13]  G. Pejler,et al.  Biology of mast cell tryptase. An inflammatory mediator. , 2006, The FEBS journal.

[14]  Y. Okayama,et al.  Development, migration, and survival of mast cells , 2006, Immunologic research.

[15]  S. Ramael,et al.  First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide , 2005, Anesthesiology.

[16]  P. Kam,et al.  Mast cell tryptase: a review of its physiology and clinical significance , 2004, Anaesthesia.

[17]  F. Alla,et al.  Anaphylactic and Anaphylactoid Reactions Occurring during Anesthesia in France in 1999–2000 , 2003, Anesthesiology.

[18]  M. Laxenaire,et al.  Anaphylaxis during anaesthesia. Results of a two-year survey in France. , 2001, British journal of anaesthesia.

[19]  M. Fisher,et al.  Rocuronium: high risk for anaphylaxis? , 2001, British journal of anaesthesia.

[20]  J. Proost,et al.  Urinary, biliary and faecal excretion of rocuronium in humans. , 2000, British journal of anaesthesia.

[21]  B. Finegan,et al.  Rocuronium anaphylaxis and multiple neuromuscular blocking drug sensitivities , 2000, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[22]  T. Heier,et al.  Anaphylactic reactions during induction of anaesthesia using rocuronium for muscle relaxation: A report including 3 cases , 2000, Acta anaesthesiologica Scandinavica.

[23]  B. Baldo,et al.  Mast cell tryptase in anaesthetic anaphylactoid reactions. , 1998, British journal of anaesthesia.

[24]  M. Rk Safety aspects of non-depolarizing neuromuscular blocking agents with special reference to rocuronium bromide. , 1994 .

[25]  R. Mirakhur Safety aspects of non-depolarizing neuromuscular blocking agents with special reference to rocuronium bromide. , 1994, European journal of anaesthesiology. Supplement.

[26]  L. Rasmussen,et al.  Horner's syndrome after long-term epidural block. , 1992, European journal of anaesthesiology.